+

WO2008145848A3 - Composition pharmaceutique et/ou cosmetique contenant des peptides derives de l ' aconitase - Google Patents

Composition pharmaceutique et/ou cosmetique contenant des peptides derives de l ' aconitase Download PDF

Info

Publication number
WO2008145848A3
WO2008145848A3 PCT/FR2008/000571 FR2008000571W WO2008145848A3 WO 2008145848 A3 WO2008145848 A3 WO 2008145848A3 FR 2008000571 W FR2008000571 W FR 2008000571W WO 2008145848 A3 WO2008145848 A3 WO 2008145848A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical
relates
composition containing
cosmetic composition
cosmetic
Prior art date
Application number
PCT/FR2008/000571
Other languages
English (en)
Other versions
WO2008145848A2 (fr
Inventor
Farra Claude Dal
Nouha Domloge
Jean-Marie Botto
Original Assignee
Soc Extraction Principes Actif
Farra Claude Dal
Nouha Domloge
Jean-Marie Botto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc Extraction Principes Actif, Farra Claude Dal, Nouha Domloge, Jean-Marie Botto filed Critical Soc Extraction Principes Actif
Publication of WO2008145848A2 publication Critical patent/WO2008145848A2/fr
Publication of WO2008145848A3 publication Critical patent/WO2008145848A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne une composition cosmétique ou pharmaceutique, et notamment dermatologique, comprenant dans un milieu physiologiquement adapté, des peptides dérivés de l'enzyme aconitase, en tant qu'agents actifs, seuls ou en association avec au moins un autre agent actif. L'invention est également relative à l'utilisation cosmétique d'une composition protectrice des mitochondries. L'invention porte encore sur un procédé de traitement cosmétique destiné à protéger la peau et les phanères des agressions extérieures et à lutter contre le vieillissement cutané.
PCT/FR2008/000571 2007-04-27 2008-04-23 Composition pharmaceutique et/ou cosmetique contenant des peptides derives de l ' aconitase WO2008145848A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0703052A FR2915396B1 (fr) 2007-04-27 2007-04-27 Composition pharmaceutique et/ou cosmetique contenant des peptides
FR0703052 2007-04-27

Publications (2)

Publication Number Publication Date
WO2008145848A2 WO2008145848A2 (fr) 2008-12-04
WO2008145848A3 true WO2008145848A3 (fr) 2009-06-18

Family

ID=38735993

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/000571 WO2008145848A2 (fr) 2007-04-27 2008-04-23 Composition pharmaceutique et/ou cosmetique contenant des peptides derives de l ' aconitase

Country Status (2)

Country Link
FR (1) FR2915396B1 (fr)
WO (1) WO2008145848A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8980876B2 (en) 2010-10-28 2015-03-17 The Procter & Gamble Company Inhibition of microbial growth by aconitase inhibition
WO2020264076A1 (fr) 2019-06-28 2020-12-30 The Procter & Gamble Company Méthode de traitement augmenté par la lumière

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020046A1 (fr) * 1994-01-25 1995-07-27 Biocem Aconitases vegetales et acides nucleiques codant pour ces aconitases
JPH07233086A (ja) * 1994-02-24 1995-09-05 Morinaga Milk Ind Co Ltd 動物皮膚病治療剤
US20040033538A1 (en) * 2002-08-16 2004-02-19 Esteban Masuda Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a C-MYC protein
WO2004043482A1 (fr) * 2002-11-08 2004-05-27 Societe D'extraction Des Principes Actifs (Vincience) Composition cosmetique ou pharmaceutique comprenant des peptides, possedant le motif arg-gly-ser
WO2006029028A2 (fr) * 2004-09-02 2006-03-16 Cognosci, Inc. Analogues d'apo e ameliores et leurs methodes d'utilisation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020046A1 (fr) * 1994-01-25 1995-07-27 Biocem Aconitases vegetales et acides nucleiques codant pour ces aconitases
JPH07233086A (ja) * 1994-02-24 1995-09-05 Morinaga Milk Ind Co Ltd 動物皮膚病治療剤
US20040033538A1 (en) * 2002-08-16 2004-02-19 Esteban Masuda Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a C-MYC protein
WO2004043482A1 (fr) * 2002-11-08 2004-05-27 Societe D'extraction Des Principes Actifs (Vincience) Composition cosmetique ou pharmaceutique comprenant des peptides, possedant le motif arg-gly-ser
WO2006029028A2 (fr) * 2004-09-02 2006-03-16 Cognosci, Inc. Analogues d'apo e ameliores et leurs methodes d'utilisation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
RZYMKIEWICZ D. ET AL.: "Induction of heme oxygenase-1 modulates cis-aconitase activity in lens epitelial cells.", BIOCHEM BIOPHYS RES COMM, vol. 270, 2 April 2000 (2000-04-02), pages 324 - 328, XP002461446 *

Also Published As

Publication number Publication date
FR2915396A1 (fr) 2008-10-31
FR2915396B1 (fr) 2012-01-20
WO2008145848A2 (fr) 2008-12-04

Similar Documents

Publication Publication Date Title
WO2009074735A3 (fr) Utilisation d'un nouvel agent naturel dans des compositions cosmetiques
WO2007002597A3 (fr) Formulations a liberation modifiee d'un sel de bupropion
PL1962815T3 (pl) Zastosowanie błonotwórczych polimerów do pielęgnacji włosów z grupy poluretanów i zawierające te polimery preparaty i plastry farmaceutyczne
WO2011061330A3 (fr) Utilisation d'agents rafraîchissants physiologiques et produits contenant de tels agents
WO2010078883A3 (fr) Agent de désinfection et de décontamination combiné à efficacité accrue
WO2007129270A3 (fr) Nouvelles compositions cosmétiques contenant au moins un peptide doté d'au moins un cycle aromatique immobilisé
WO2008139122A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
WO2006103037A3 (fr) Composition contenant la $g(b)-defensine 2
WO2010031657A3 (fr) Utilisation de dérivés d'urée et de sels de phenacyl thiazolium pour le traitement d'odeurs corporelles
WO2007127333A3 (fr) Compositions pour le traitement et la prévention du gonflement des paupières
WO2006135854A3 (fr) Compositions antiseptiques
WO2010010470A3 (fr) Procédé d’administration de formulations antifongiques topiques pour le traitement d’infections fongiques
WO2007130725A3 (fr) Utilisation de hmgb1 en protection contre les lésions de reperfusion de l'ischémie
WO2009061431A3 (fr) Compositions pour le traitement et la prévention du gonflement des paupières
EP2144608A4 (fr) Compositions d'écran solaire et procédés
WO2008042480A3 (fr) Inhibiteurs époxyde de cystéine protéases
WO2008145849A3 (fr) Composition pharmaceutique et/ou cosmetique contenant des peptides derives de l'aconitase
WO2008139123A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
WO2007077318A3 (fr) Utilisation d'un extrait peptidique de riz en tant qu'agent actif inducteur de la synthese des proteines sirt dans les cellules de la peau
PL1868631T3 (pl) Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej
WO2008145848A3 (fr) Composition pharmaceutique et/ou cosmetique contenant des peptides derives de l ' aconitase
WO2010112712A3 (fr) Peptides anti-age activateurs du proteasome et compositions les contenant
WO2008050157A3 (fr) Formulations d'huile ozonisée
WO2006018454A3 (fr) Preparation cosmetique contenant de l'acide hyaluronique
WO2010112710A3 (fr) Peptides anti-age activateurs du proteasome et compositions les contenant

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08805490

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08805490

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载